IL116485A0 - Monocyclic beta-lactams for use in inhibiting lrho pla2 - Google Patents
Monocyclic beta-lactams for use in inhibiting lrho pla2Info
- Publication number
- IL116485A0 IL116485A0 IL11648595A IL11648595A IL116485A0 IL 116485 A0 IL116485 A0 IL 116485A0 IL 11648595 A IL11648595 A IL 11648595A IL 11648595 A IL11648595 A IL 11648595A IL 116485 A0 IL116485 A0 IL 116485A0
- Authority
- IL
- Israel
- Prior art keywords
- lrho
- pla2
- lactams
- inhibiting
- monocyclic beta
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9426020.5A GB9426020D0 (en) | 1994-12-22 | 1994-12-22 | Novel compounds |
GBGB9426030.4A GB9426030D0 (en) | 1994-12-23 | 1994-12-23 | Novel compounds |
GBGB9511599.4A GB9511599D0 (en) | 1995-06-08 | 1995-06-08 | Novel compounds |
GBGB9511600.0A GB9511600D0 (en) | 1995-06-08 | 1995-06-08 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
IL116485A0 true IL116485A0 (en) | 1996-08-04 |
Family
ID=27451242
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11648595A IL116485A0 (en) | 1994-12-22 | 1995-12-21 | Monocyclic beta-lactams for use in inhibiting lrho pla2 |
Country Status (24)
Country | Link |
---|---|
US (1) | US5990102A (xx) |
EP (1) | EP0799200A1 (xx) |
JP (1) | JPH11500415A (xx) |
CN (1) | CN1175246A (xx) |
AP (1) | AP9701007A0 (xx) |
AR (1) | AR002012A1 (xx) |
AU (1) | AU704407B2 (xx) |
BG (1) | BG101687A (xx) |
BR (1) | BR9510420A (xx) |
CA (1) | CA2208530A1 (xx) |
CZ (1) | CZ192297A3 (xx) |
DZ (1) | DZ1958A1 (xx) |
FI (1) | FI972584A (xx) |
HU (1) | HUT77089A (xx) |
IL (1) | IL116485A0 (xx) |
MA (1) | MA23834A1 (xx) |
MX (1) | MX9704736A (xx) |
NO (1) | NO972909L (xx) |
NZ (1) | NZ298416A (xx) |
OA (1) | OA10737A (xx) |
PL (1) | PL320937A1 (xx) |
SK (1) | SK80397A3 (xx) |
TR (1) | TR199501655A2 (xx) |
WO (1) | WO1996019451A1 (xx) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SK178497A3 (en) * | 1995-07-01 | 1998-07-08 | Smithkline Beecham Plc | Azetidinone derivatives, method for producing the same, pharmaceutical composition containing same and their use |
WO1997021676A1 (en) * | 1995-12-08 | 1997-06-19 | Smithkline Beecham Plc | Azetidinone compounds for the treatment of atherosclerosis |
EP0869943A1 (en) * | 1995-12-08 | 1998-10-14 | Smithkline Beecham Plc | Monocyclic beta-lactame derivatives for treatment of atherosclerosis |
EP0915843A1 (en) * | 1996-04-26 | 1999-05-19 | Smithkline Beecham Plc | Azetidinone derivatives for the treatment of atheroscleroses |
GB9608649D0 (en) * | 1996-04-26 | 1996-07-03 | Smithkline Beecham Plc | Novel compounds |
AU4654199A (en) * | 1998-07-23 | 2000-02-14 | Shionogi & Co., Ltd. | Monocyclic beta-lactam compounds and chymase inhibitors containing the same |
CZ304450B6 (cs) | 2000-02-16 | 2014-05-14 | Smithkline Beecham P. L. C. | Pyrimidinový derivát |
GB0024808D0 (en) | 2000-10-10 | 2000-11-22 | Smithkline Beecham Plc | Novel compounds |
US6982251B2 (en) * | 2000-12-20 | 2006-01-03 | Schering Corporation | Substituted 2-azetidinones useful as hypocholesterolemic agents |
CN1756756A (zh) | 2003-03-07 | 2006-04-05 | 先灵公司 | 取代的2-吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途 |
ATE406364T1 (de) | 2003-03-07 | 2008-09-15 | Schering Corp | Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia |
US7192944B2 (en) * | 2003-03-07 | 2007-03-20 | Schering Corp. | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
EP1747014A4 (en) * | 2004-05-03 | 2007-09-12 | Ilypsa Inc | MODULATION OF LYSOPHOSPHATIDYLCHOLINE AND TREATMENT OF CONDITIONS INDUCED BY A DIET |
EP2152865B1 (en) | 2007-05-11 | 2015-04-15 | Thomas Jefferson University | Methods of treatment and prevention of neurodegenerative diseases and disorders |
US8962633B2 (en) | 2007-05-11 | 2015-02-24 | Thomas Jefferson University | Methods of treatment and prevention of metabolic bone diseases and disorders |
EA018101B1 (ru) | 2007-05-11 | 2013-05-30 | Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания | Способы лечения кожных язв |
CA2820408C (en) | 2010-12-06 | 2018-03-06 | Glaxo Group Limited | Pyrimidinone compounds for use in the treatment of diseases or conditions mediated by lp-pla2 |
EP2651403B1 (en) | 2010-12-17 | 2020-12-02 | Glaxo Group Limited | Use of lp-pla2 inhibitors in the treatment and prevention of eye diseases |
US20140171431A1 (en) | 2011-06-27 | 2014-06-19 | Jianhua Shen | Azole heterocyclic compound, preparation method, pharmaceutical composition and use |
CA2843102A1 (en) | 2011-07-27 | 2013-01-31 | Glaxo Group Limited | Bicyclic pyrimidone compounds |
KR20140059203A (ko) | 2011-07-27 | 2014-05-15 | 글락소 그룹 리미티드 | 2,3-디히드로이미다조[1,2-c]피리미딘-5(1h)-온 화합물의 lp-pla2 억제제로서의 용도 |
CN105008365B (zh) | 2013-01-25 | 2017-03-15 | 葛兰素史密斯克莱知识产权发展有限公司 | 化合物 |
CN105008368B (zh) | 2013-01-25 | 2017-02-01 | 葛兰素史密斯克莱知识产权发展有限公司 | 基于2,3‑二氢咪唑并[1,2‑c]嘧啶‑5(1H)‑酮的脂蛋白相关磷脂酶A2(Lp‑PLA2)抑制剂 |
BR112015017397A2 (pt) | 2013-01-25 | 2017-07-11 | Glaxosmithkline Ip Dev Ltd | compostos pirimidona bicíclica como inibidores de lp-pla2 |
WO2015179293A1 (en) * | 2014-05-18 | 2015-11-26 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Small molecule activators and inhibitors of lecithin: cholesterol acyltransferase |
WO2016012917A1 (en) | 2014-07-22 | 2016-01-28 | Glaxosmithkline Intellectual Property Development Limited | 1,2,3,5-tetrahydroimidazo[1,2-c]pyrimidine derivatives useful in the treatment of diseases and disorders mediated by lp-pla2 |
WO2016012916A1 (en) | 2014-07-22 | 2016-01-28 | Glaxosmithkline Intellectual Property Development Limited | 1,2,3,5-tetrahydroimidazo[1,2-c]pyrimidine derivatives useful in the treatment of diseases and disorders mediated by lp-pla2 |
CA3156783A1 (en) | 2019-11-09 | 2021-05-14 | Yun Jin | Tricycle dihydroimidazopyrimidone derivative, preparation method thereof, pharmaceutical composition and use thereof |
CN115304620A (zh) | 2021-05-07 | 2022-11-08 | 上海赛默罗生物科技有限公司 | 嘧啶酮衍生物、其制备方法、药物组合物和用途 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0010358A1 (en) * | 1978-09-20 | 1980-04-30 | Glaxo Group Limited | Beta-lactam compounds, processes for their preparation, compositions containing them, intermediates of use in their preparation and methods for the production thereof |
US4680391A (en) * | 1983-12-01 | 1987-07-14 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
IL99658A0 (en) * | 1990-10-15 | 1992-08-18 | Merck & Co Inc | Substituted azetidinones and pharmaceutical compositions containing them |
-
1995
- 1995-12-20 CA CA002208530A patent/CA2208530A1/en not_active Abandoned
- 1995-12-20 BR BR9510420-8A patent/BR9510420A/pt unknown
- 1995-12-20 CN CN95197606A patent/CN1175246A/zh active Pending
- 1995-12-20 NZ NZ298416A patent/NZ298416A/xx unknown
- 1995-12-20 SK SK803-97A patent/SK80397A3/sk unknown
- 1995-12-20 JP JP8519527A patent/JPH11500415A/ja active Pending
- 1995-12-20 CZ CZ971922A patent/CZ192297A3/cs unknown
- 1995-12-20 MX MX9704736A patent/MX9704736A/es unknown
- 1995-12-20 AP APAP/P/1997/001007A patent/AP9701007A0/en unknown
- 1995-12-20 DZ DZ950141A patent/DZ1958A1/fr active
- 1995-12-20 AR ARP950100660A patent/AR002012A1/es unknown
- 1995-12-20 HU HU9701948A patent/HUT77089A/hu unknown
- 1995-12-20 AU AU43898/96A patent/AU704407B2/en not_active Ceased
- 1995-12-20 EP EP95942734A patent/EP0799200A1/en not_active Withdrawn
- 1995-12-20 PL PL95320937A patent/PL320937A1/xx unknown
- 1995-12-20 WO PCT/EP1995/005130 patent/WO1996019451A1/en not_active Application Discontinuation
- 1995-12-20 MA MA24105A patent/MA23834A1/fr unknown
- 1995-12-20 US US08/860,162 patent/US5990102A/en not_active Expired - Fee Related
- 1995-12-21 IL IL11648595A patent/IL116485A0/xx unknown
- 1995-12-22 TR TR95/01655A patent/TR199501655A2/xx unknown
-
1997
- 1997-06-17 FI FI972584A patent/FI972584A/fi unknown
- 1997-06-20 NO NO972909A patent/NO972909L/no unknown
- 1997-06-20 OA OA70034A patent/OA10737A/en unknown
- 1997-06-26 BG BG101687A patent/BG101687A/xx active Pending
Also Published As
Publication number | Publication date |
---|---|
JPH11500415A (ja) | 1999-01-12 |
AU704407B2 (en) | 1999-04-22 |
TR199501655A2 (tr) | 1996-07-21 |
MX9704736A (es) | 1997-10-31 |
CA2208530A1 (en) | 1996-06-27 |
EP0799200A1 (en) | 1997-10-08 |
SK80397A3 (en) | 1998-01-14 |
MA23834A1 (fr) | 1996-10-01 |
OA10737A (en) | 2002-12-10 |
WO1996019451A1 (en) | 1996-06-27 |
AR002012A1 (es) | 1998-01-07 |
AP9701007A0 (en) | 1997-07-31 |
CZ192297A3 (en) | 1997-11-12 |
NO972909L (no) | 1997-08-20 |
US5990102A (en) | 1999-11-23 |
PL320937A1 (en) | 1997-11-10 |
AU4389896A (en) | 1996-07-10 |
FI972584A0 (fi) | 1997-06-17 |
BG101687A (en) | 1998-02-27 |
FI972584A (fi) | 1997-08-19 |
NZ298416A (en) | 1999-03-29 |
BR9510420A (pt) | 2004-04-20 |
HUT77089A (hu) | 1998-03-02 |
DZ1958A1 (fr) | 2002-02-17 |
CN1175246A (zh) | 1998-03-04 |
NO972909D0 (no) | 1997-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL116485A0 (en) | Monocyclic beta-lactams for use in inhibiting lrho pla2 | |
DE69834346D1 (en) | Proteinexpression in baculovirus-vektor expressionsystemen | |
PL331338A1 (en) | Thiosulphonamidic metaloprotease inhibitors | |
GB2320435B (en) | Improvements in Magnotherapy | |
PL331803A1 (en) | Bidonoric metaloprotease inhibitors | |
GB2293372B (en) | Improvements in refining | |
GB9400538D0 (en) | Hydrate inhibition | |
DE69732623D1 (en) | Analogsignalmultiplexer in strombetriebsart | |
EP0765713A3 (en) | Sanding sheets | |
HU9503783D0 (en) | Squvalen syntetase inhibitors | |
GB9416179D0 (en) | Abrasive elements | |
GB9916008D0 (en) | Sharpening arrangement | |
GB9401593D0 (en) | Surface grinding | |
GB2306985B (en) | Improvements in milling | |
GB2293779B (en) | Edge mill | |
GB9504832D0 (en) | Improvements in lockig means | |
GB2316909B (en) | Banknote | |
GB9816215D0 (en) | 2 In 1 airjack | |
PL105123U1 (en) | Holder in particular for dishtowels | |
GB9401702D0 (en) | Tickets | |
GB9411007D0 (en) | Improvements in flylines | |
GB9420877D0 (en) | Improvements in refractories | |
GB9804091D0 (en) | Improvements in keyholders | |
GB9822471D0 (en) | Sanding paper dispener | |
HU9400235V0 (en) | Drink-paccked in boxes-pouring |